Sepsis Due To Staphylococcus Aureus — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for sepsis due to staphylococcus aureus. 11 active patents protecting 1 drugs from 1+ originators. First major cliff: 2028. Daily refresh.

1
Approved drugs
11
Active US patents
63/100
Avg vulnerability
—
Annual revenue covered

Originators in Sepsis Due To Staphylococcus Aureus

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Baxter 11 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating sepsis due to staphylococcus aureus. Each bar = one year. Y-axis scaled to peak year (4 patents).

1
28
1
30
4
33
4
38
1
41

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Cubicin
Daptomycin
 Baxter 11 63 — 2028-09-04

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8003673 Cubicin method of use 80 2028-09-04
12053502 Cubicin method of use 75 2038-08-28
12053502 Cubicin method of use 75 2038-08-28
11173189 Cubicin method of use 70 2041-03-11
9655946 Cubicin method of use 62 2033-09-11
10357535 Cubicin method of use 62 2033-09-11
9655946 Cubicin method of use 62 2033-09-11
10357535 Cubicin method of use 62 2033-09-11
11759497 Cubicin formulation 50 2038-08-28
11759497 Cubicin formulation 50 2038-08-28

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
9138456 Cubicin formulation 48 2030-11-23
11759497 Cubicin formulation 50 2038-08-28
11759497 Cubicin formulation 50 2038-08-28
9655946 Cubicin method of use 62 2033-09-11
10357535 Cubicin method of use 62 2033-09-11
10357535 Cubicin method of use 62 2033-09-11
9655946 Cubicin method of use 62 2033-09-11
11173189 Cubicin method of use 70 2041-03-11
12053502 Cubicin method of use 75 2038-08-28
12053502 Cubicin method of use 75 2038-08-28

Related